BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Niu TH, Jiang M, Xin YN, Jiang XJ, Lin ZH, Xuan SY. Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population. World J Gastroenterol 2014; 20(13): 3655-3662 [PMID: 24707151 DOI: 10.3748/wjg.v20.i13.3655]
URL: https://www.wjgnet.com/1007-9327/full/v20/i13/3655.htm
Number Citing Articles
1
Renfan Xu, Anyu Tao, Shasha Zhang, Youbin Deng, Guangzhi Chen. Association Between Patatin-Like Phospholipase Domain Containing 3 Gene (PNPLA3) Polymorphisms and Nonalcoholic Fatty Liver Disease: A HuGE Review and Meta-AnalysisScientific Reports 2015; 5(1) doi: 10.1038/srep09284
2
Bing-Feng Chen, Yeuh Chien, Pin-Hsing Tsai, Pang-Chung Perng, Yi-Ping Yang, Kuan-Chun Hsueh, Chia-Hung Liu, Yuan-Hung Wang. A PRISMA-compliant meta-analysis of apolipoprotein C3 polymorphisms and nonalcoholic fatty liver diseaseJournal of the Chinese Medical Association 2021; 84(10): 923 doi: 10.1097/JCMA.0000000000000564
3
Yun Tao, Yisong Xiong, Huimin Wang, Shaopeng Chu, Renqian Zhong, Jianxin Wang, Guihua Wang, Xiumei Ren, Juan Yu. APOC3 induces endothelial dysfunction through TNF-α and JAM-1Lipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0326-0
4
Guangrong Dai, Pengfei Liu, Xiaomei Li, Xiaoyan Zhou, Shuixiang He. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severityMedicine 2019; 98(7): e14324 doi: 10.1097/MD.0000000000014324
5
Xiao-Lin Li, Jian-Qing Sui, Lin-Lin Lu, Nan-Nan Zhang, Xin Xu, Quan-Yong Dong, Yong-Ning Xin, Shi-Ying Xuan. Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise reviewLipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0221-8
6
Audrey Deprince, Joel T. Haas, Bart Staels. Dysregulated lipid metabolism links NAFLD to cardiovascular diseaseMolecular Metabolism 2020; 42: 101092 doi: 10.1016/j.molmet.2020.101092
7
Garam Jo, So-Young Kwak, Ji Kim, Hyunjung Lim, Min-Jeong Shin. Association between Genetic Variant of Apolipoprotein C3 and Incident Hypertension Stratified by Obesity and Physical Activity in KoreaNutrients 2018; 10(11): 1595 doi: 10.3390/nu10111595
8
Reina Yamamoto, Yumie Takeshita, Hiromasa Tsujiguchi, Takayuki Kannon, Takehiro Sato, Kazuyoshi Hosomichi, Keita Suzuki, Yuki Kita, Takeo Tanaka, Hisanori Goto, Yujiro Nakano, Tatsuya Yamashita, Shuichi Kaneko, Atsushi Tajima, Hiroyuki Nakamura, Toshinari Takamura. Nutrigenetic Interaction Between Apolipoprotein C3 Polymorphism and Fat Intake in People with Nonalcoholic Fatty Liver DiseaseCurrent Developments in Nutrition 2023; 7(4): 100051 doi: 10.1016/j.cdnut.2023.100051
9
Magdy M. Youssef, Amal Elshaer, Rizk Elbaz, Yehia A. Ellazek, Ahmad El-Waseef, Ahmad Settin. ApolipoproteinC3 Gene Variants in Nonalcoholic Fatty Liver Disease in EgyptAmerican Journal of Biochemistry and Molecular Biology 2017; 8(1): 16 doi: 10.3923/ajbmb.2018.16.22
10
Bai-Quan An, Lin-Lin Lu, Chen Yuan, Yong-Ning Xin, Shi-Ying Xuan. Leptin Receptor Gene Polymorphisms and the Risk of Non-Alcoholic Fatty Liver Disease and Coronary Atherosclerosis in the Chinese Han PopulationHepatitis Monthly 2016; 16(4) doi: 10.5812/hepatmon.35055
11
Rui-Nan Zhang, Rui-Dan Zheng, Yu-Qiang Mi, Da Zhou, Feng Shen, Guang-Yu Chen, Chan-Yan Zhu, Qin Pan, Jian-Gao Fan. APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver DiseasesDigestive Diseases and Sciences 2016; 61(8): 2284 doi: 10.1007/s10620-016-4120-7
12
Meng-Juan Wu, Chen Yuan, Lin-Lin Lu, Bai-Quan An, Shi-Ying Xuan, Yong-Ning Xin. Role of NCAN rs2228603 polymorphism in the incidence of nonalcoholic fatty liver disease: a case-control studyLipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0367-4
13
Sara Saki, Nader Saki, Hossein Poustchi, Reza Malekzadeh. Assessment of Genetic Aspects of Non-alcoholic Fatty Liver and Premature Cardiovascular EventsMiddle East Journal of Digestive Diseases 2020; 12(2): 65 doi: 10.34172/mejdd.2020.166
14
Fabio Salvatore Macaluso, Marcello Maida, Salvatore Petta. Genetic background in nonalcoholic fatty liver disease: A comprehensive reviewWorld Journal of Gastroenterology 2015; 21(39): 11088-11111 doi: 10.3748/wjg.v21.i39.11088
15
Shi Cheng, Bo Pang, Chun Gu, Shi-Peng Sun, Cheng An, Zhen-Peng Zhang, Jun Li, Gui-Jian Liu. Association between apolipoprotein C3 gene promoter polymorphisms and fasting triglyceride level: A meta-analysisFrontiers in Laboratory Medicine 2017; 1(3): 151 doi: 10.1016/j.flm.2017.10.002
16
Long Zhang, Wei You, Hanze Zhang, Rui Peng, Qin Zhu, Aihua Yao, Xiangcheng Li, Yebin Zhou, Xuehao Wang, Liyong Pu, Jindao Wu. PNPLA3 polymorphisms (rs738409) and non‐alcoholic fatty liver disease risk and related phenotypes: a meta‐analysisJournal of Gastroenterology and Hepatology 2015; 30(5): 821 doi: 10.1111/jgh.12889
17
Li-Zhen Chen, Hong-Yun Ding, Shou-Sheng Liu, Qun Liu, Xiang-Jun Jiang, Yong-Ning Xin, Shi-Ying Xuan. Combining I148M and E167K variants to improve risk prediction for nonalcoholic fatty liver disease in Qingdao Han population, ChinaLipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-0992-9
18
Chen Yuan, Linlin Lu, Baiquan An, Wenwen Jin, Quanjiang Dong, Yongning Xin, Shiying Xuan. Association Between LYPLAL1 rs12137855 Polymorphism With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease in a Chinese Han PopulationHepatitis Monthly 2015; 15(12) doi: 10.5812/hepatmon.33155
19
Min-Rui Li, Sheng-Hong Zhang, Kang Chao, Xian-Hua Liao, Jia-Yan Yao, Min-Hu Chen, Bi-Hui Zhong. <italic>Apolipoprotein C3</italic> (-455T&gt;C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese populationWorld Journal of Gastroenterology 2014; 20(38): 14010-14017 doi: 10.3748/wjg.v20.i38.14010
20
Wen-Yue Liu, Mohammed Eslam, Kenneth I. Zheng, Hong-Lei Ma, Rafael S. Rios, Min-Zhi Lv, Gang Li, Liang-Jie Tang, Pei-Wu Zhu, Xiao-Dong Wang, Christopher D. Byrne, Giovanni Targher, Jacob George, Ming-Hua Zheng. Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver DiseaseJournal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00151
21
Yuexin Zhang, Wen Cai, Jiangmei Song, Lei Miao, Bei Zhang, Qin Xu, Lijuan Zhang, Hua Yao, Junwen Wang. Association between the PNPLA3 I148M Polymorphism and Non-Alcoholic Fatty Liver Disease in the Uygur and Han Ethnic Groups of Northwestern ChinaPLoS ONE 2014; 9(10): e108381 doi: 10.1371/journal.pone.0108381
22
Giuseppina Umano, Mariangela Martino, Nicola Santoro. The Association between Pediatric NAFLD and Common Genetic VariantsChildren 2017; 4(6): 49 doi: 10.3390/children4060049
23
Xiaoyun Cheng, Jun Yamauchi, Sojin Lee, Ting Zhang, Zhenwei Gong, Radhika Muzumdar, Shen Qu, H. Henry Dong. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in MiceJournal of Biological Chemistry 2017; 292(9): 3692 doi: 10.1074/jbc.M116.765917
24
Genetics of nonalcoholic fatty liver disease in Asian populationsJournal of Genetics 2019; 98(1) doi: 10.1007/s12041-019-1071-8
25
Haiying Zhang, Lizhen Chen, Yongning Xin, Yuangui Lou, Yang Liu, Shiying Xuan. Apolipoprotein C3 Gene Polymorphisms Are Not a Risk Factor for Developing Non-Alcoholic Fatty Liver Disease: A Meta-AnalysisHepatitis Monthly 2014; 14(10) doi: 10.5812/hepatmon.23100
26
Yan Zhao, Wenli Zhao, Jingchao Ma, Maeda Toshiyoshi, Ye Zhao. Patatin-like phospholipase domain-containing 3 gene (PNPLA3) polymorphic (rs738409) single nucleotide polymorphisms and susceptibility to nonalcoholic fatty liver disease: A meta-analysis of twenty studiesMedicine 2023; 102(10): e33110 doi: 10.1097/MD.0000000000033110
27
Nader Salari, Niloufar Darvishi, Kamran Mansouri, Hooman Ghasemi, Melika Hosseinian-Far, Fateme Darvishi, Masoud Mohammadi. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysisBMC Endocrine Disorders 2021; 21(1) doi: 10.1186/s12902-021-00789-4